Misstear K. McNeela EA, Murphy AG, Geoghegan JA, O'Keeffe KM, Fox J, Chan K, Heuking S, Collin N, Foster TJ, McLoughlin RM and  Lavelle EC.  (2013).  Targeted nasal vaccination provides antibody independent protection against Staphylococcus aureus.  The Journal of Infectious Diseases, Nov 22, 2013 doi:10.1093/infdis/jit636 (TRANSVAC)

Weiner J. Maertzdorf J, Kaufmann SH.  (2013).  The dual role of biomarkers for understanding basic principles and devising novel intervention strategies in tuberculosis. Annals of the New York Academy of Sciences, 1283: 22-29.  doi:10.1111/j.1749-6632.2012.06802.x (TRANSVAC)

Ndungu FM, Lundblom K, Rono J, Illingworth J, Eriksson S, Färnert A.  A. Long-livedPlasmodium falciparum specific memory B cells in naturally exposed Swedish travellers. European Journal of Immunology, 2013 Nov. 43(11): 2919-29.  doi: 10.1002/eji.201343630 (MVVC)

Kaufmann S. H. E. and Dorhoi A. (2013).  Inflammation in tuberculosis: interactions, imbalances and interventions.  Current Opinion in Immunology, 25(4): 441-449.  doi:10.1016/j.coi.2013.05.005 (TRANSVAC)

Micha Phill Grønholm Jepsen, Prajakta S. Jogdand, Susheel K. Singh, Meral Esen, Michael Christiansen, Saadou Issifou, Aurore B. Hounkpatin, Ulysse Ateba-Ngoa, Peter G. Kremsner, Morten H. Dziegiel, Severin Olesen-Larsen, Søren Jepsen, Benjamin Mordmüller, Michael Theisen.  The Malaria Vaccine Candidate GMZ2 Elicits Functional Antibodies in Individuals From Malaria Endemic and Non-Endemic Areas.  The Journal of Infectious Diseases,  volume 208, issue 3 (EMVDA)

Kaufmann S. H. E. [R1] (2013).  Tuberculosis vaccines: Time to think about the next generation.  Seminars in Immunology, 25(2): 172-181.  doi:10.1016/j.smim.2013.04.006 (TRANSVAC)

Bonhoeffer J, Imoukhuede B, Aldrovandi G, Bachtiar NS, Chan ES, Chang S, Chen RT, Fernandopulle R, Goldenthal KL, Heffelfinger JD, Hossain S, Jevaji I, Khamesipour A, Kochhar S, Makhene M, Malkin E, Nalin D, Prevots R, Ramasamy R, Sellers S, Vekemans J, Walker B, Wilson P, Wong V, Zaman K, Heininger U; for the Brighton Collaboration Clinical Trial Protocol Working Group. Template protocol for clinical trials investigating vaccines-Focus on safety elements. Vaccine. 2013 Mar 11. doi:pii: S0264-410X(13)00230-2. 10.1016/j.vaccine.2013.02.041. PMID: 23499603 (INYVAX)

Caroline Ogwang, Muhammed Afolabi., Domtila Kimani, Ya Jankey Jagne, Susanne H. Sheehy, Carly M. Bliss, Christopher J. A. Duncan, Katharine A. Collins, Miguel A. Garcia Knight, Eva Kimani, Nicholas A. Anagnostou, Eleanor Berrie, Sarah Moyle, Sarah C. Gilbert, Alexandra J. Spencer, Peninah Soipei, Jenny Mueller, Joseph Okebe, Stefano Colloca, Riccardo Cortese, Nicola K. Viebig, Rachel Roberts, Katherine Gantlett, Alison M. Lawrie, Alfredo Nicosia, Egeruan B. Imoukhuede, Philip Bejon, Britta C. Urban, Katie L. Flanagan, Katie J. Ewer, Roma Chilengi, Adrian V. S. Hill, Kalifa Bojang.  Safety and Immunogenicity of Heterologous Prime-Boost Immunisation with Plasmodium falciparum Malaria Candidate Vaccines, ChAd63 ME-TRAP and MVA METRAP, in Healthy Gambian and Kenyan Adults.  Plos one, 2013;8(3):e57726. doi: 10.1371/journal.pone.0057726 (MVVC)

Petruccioli E, Petrone L, Vanini V, Sampaolesi A, Gualano G, Girardi E, Palmieri F, Goletti D.  (2013).  IFNγ/TNFα specific-cells and effector memory phenotype associate with active tuberculosis.  The Journal of Infection.  doi: 10.1016/j.jinf.2013.02.004 (IDEA)

Labuda LA, Ateba-Ngoa U, Feugap EN, Heeringa JJ, van der Vlugt LE, Pires RB, Mewono L, Kremsner PG, van Zelm MC, Adegnika AA, Yazdanbakhsh M, Smits HH.  (2013).  Alterations in peripheral blood B cell subsets and dynamics of B cell responses during human schistosomiasis.  PLoS Neglected Tropical Diseases, 7(3).  doi: 10.1371/journal.pntd.0002094 (IDEA)

Illingworth J, Butler NS, Roetynck S, Mwacharo J, Pierce SK, Bejon P, Crompton PD, Marsh K and Ndungu FM.  Chronic Exposure to Plasmodium falciparum is associated with phenotypic evidence of B and T-cell exhaustion.  Immunol. 2013 Feb 1;190(3):1038-47. doi: 10.4049/jimmunol.1202438. Epub 2012 Dec 21 (MVVC)

Grode L. Ganoza CA, Brohm C, Weiner J 3rd, Eisele B, Kaufmann SH. (2013).  Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial.  Vaccine, 31(9): 1340-1348.  doi:10.1016/j.vaccine.2012.12.053 (TRANSVAC)

Goletti D, Petruccioli E, Romagnoli A, Piacentini M, Fimia GM.  (2013).  Autophagy in Mycobacterium tuberculosis infection: A passepartout to flush the intruder out? Cytokine & Growth Factor Reviews, 24(4): 335-43.  doi: 10.1016/j.cytogfr.2013.01.002 (IDEA)

P. Riese, K. Schulze, T. Ebesen, B. Prochnow, C. A. Guzman.  Vaccine adjuvants: key tools for innovative vaccine design. Curr Top Med Chem, 2013; 13 (20): 2562 - 80 (TRANSVAC)